The Patent Finder

Shire Biochem Inc.

Also on record
Records under this name other than patents Shire Biochem Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Shire Biochem Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,595,057Streptococcus Pyogenes Antigens and Corresponding DNA Fragments
Formerly held
Term ended
Term ended Dec 5, 2025 · High confidence
Term endedTerm ended Dec 5, 2025High confidence
US 7,955,835Stereoselective Process for the Production of Dioxolane Nucleoside Analogues
Formerly held
Term ended
Term ended Jun 13, 2025 · High confidence
Term endedTerm ended Jun 13, 2025High confidence
US 7,914,794Novel Group B Streptococcus Antigens
Formerly held
Term ended
Term ended Jan 3, 2025 · Medium confidence
Term endedTerm ended Jan 3, 2025Medium confidence
US 7,465,465Pharmaceutical Formulation Comprising Lanthanum Compounds
Formerly held
Term ended
Term ended Oct 9, 2024 · High confidence
Term endedTerm ended Oct 9, 2024High confidence
US RE39,155Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
Term ended
Term ended Jul 4, 2023 · USPTO record
Term endedTerm ended Jul 4, 2023USPTO record
US 7,393,536Group B Streptococcus Antigens and Corresponding DNA Fragments
Formerly held
Term ended
Term ended May 22, 2023 · High confidence
Term endedTerm ended May 22, 2023High confidence
US 7,335,368BVH-A2 and BVH-A3 Antigens of Group B Streptococcus
Formerly held
Term ended
Term ended May 3, 2023 · High confidence
Term endedTerm ended May 3, 2023High confidence
US 7,442,813Process for Producing Dioxolane Nucleoside Analogues
Held by another company
Term ended
Term ended Jan 23, 2023 · High confidence
Term endedTerm ended Jan 23, 2023High confidence
US 6,645,972Methods of Treating Leukemia
Formerly held
Term ended
Term ended Nov 4, 2022 · High confidence
Term endedTerm ended Nov 4, 2022High confidence
US 6,800,639Pharmaceutical Combination for the Treatment of Cancer
Formerly held
Term ended
Term ended Mar 25, 2022 · High confidence
Term endedTerm ended Mar 25, 2022High confidence
10 of 50 patents shown.
Pro members see all 50.
Pro members: see all 50 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited